Zusammenfassung
Kinderwunschpatientinnen in der Dysplasiesprechstunde stellen den Behandelnden vor eine Herausforderung: Eine etwaige Dysplasie sollte vor einer geplanten Schwangerschaft möglichst saniert werden, andererseits kann eine Übertherapie Fertilitätseinschränkungen und Schwangerschaftsrisiken bedeuten. Zervixkarzinompatientinnen mit Kinderwunsch kann bis zum Stadium FIGO IB1 <2 cm ein Fertilitätserhalt mit Trachelektomie und pelviner Lymphonodektomie angeboten werden. Aktuelle Daten unterstützen den Fertilitätserhalt durch neoadjuvante Chemotherapie und konsekutive Trachelektomie auch in höheren Stadien. Während der Schwangerschaft muss die Differenzierung einer Dysplasie von der seltenen Diagnose eines Zervixkarzinoms in graviditate sorgfältig erfolgen, da klassische Zervixkarzinomsymptome in dieser Zeit fehlinterpretiert werden können. Tumorstadium und Schwangerschaftswoche sind für das Management entscheidend. Ein Staging mittels laparoskopischer pelviner Lymphonodektomie ist auch in der Schwangerschaft möglich. In fortgeschrittenen Stadien ermöglicht die neoadjuvante Chemotherapie eine Fortführung der Schwangerschaft.
Abstract
Therapeutic management of patients who wish to conceive and who present with intraepithelial lesions of the cervix uteri can be challenging: high-grade squamous intraepithelial lesions (HSIL) should be ruled out before pregnancy, while excessive conization should be avoided with regard to the risks of sterility and unfavorable impact on obstetric outcome. Cervical cancer patients who wish to conceive can opt for trachelectomy and pelvic lymphadenectomy in case of FIGO IB1 <2 cm. In larger carcinoma, cisplatin-based neoadjuvant chemotherapy for downstaging is favorable. In pregnancy, dysplastic lesions must be distinguished from invasive carcinoma. Therapeutic management depends on tumor stage and trimester. Pelvic lymphonodectomy can be performed during pregnancy. In distinct cases, neoadjuvant chemotherapy is an option.
Literatur
RKI (2015) Krebs in Deutschland 2011/2012. Zentrum für Krebsregisterdaten, Berlin, S 10
Gieseking FK (2015) Die aktuellen Empfehlungen der AG-CPC zur Kolposkopie. Gyn 20:25–47
Friese K et al (2008) AWMF Leitlinie: Prävention, Diagnostik und Therapie der HPV-Infektion und präinvasiver Läsionen des weiblichen Genitale
Kyrgiou M et al (2014) Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis. BMJ 349:g6192
Martyn FM et al (2015) Excisional treatments of the cervix and effect on subsequent fertility: a retrospective cohort study. Eur J Obstet Gynecol Reprod Biol 185:114–120
Spracklen CN et al (2013) Cervical surgery for cervical intraepithelial neoplasia and prolonged time to conception of a live birth: a case-control study. BJOG 120(8):960–965
Jin G et al (2014) Pregnancy outcome following loop electrosurgical excision procedure (LEEP) a systematic review and meta-analysis. Arch Gynecol Obstet 289(1):85–99
Castanon A et al (2015) Is the increased risk of preterm birth following excision for cervical intraepithelial neoplasia restricted to the first birth post treatment? BJOG 122(9):1191–1199
Baldauf JJ et al (2014) Prevention of obstetrical complications following LEEP, is it possible? J Gynecol Obstet Biol Reprod (Paris) 43(1):19–25
Khalid S et al (2012) The thickness and volume of LLETZ specimens can predict the relative risk of pregnancy-related morbidity. BJOG 119(6):685–691
Schwarz TM et al (2015) Comparison of two surgical methods for the treatment of CIN: classical LLETZ (large-loop excision of the transformation zone) versus isolated resection of the colposcopic apparent lesion – study protocol for a randomized controlled trial. Trials 16:225
Tasci T et al (2015) Is there any predictor for residual disease after cervical conization with positive surgical margins for HSIL or microinvasive cervical cancer? J Low Genit Tract Dis 19(2):115–118
Nam KH et al (2010) Pregnancy outcome after cervical conization: risk factors for preterm delivery and the efficacy of prophylactic cerclage. J Gynecol Oncol 21(4):225–229
Leitlinienprogramm Onkologie (2014) S3 Leitlinie Diagnostik und Therapie Zervixkarzinom
Pareja R et al (2015) Immediate radical trachelectomy versus neoadjuvant chemotherapy followed by conservative surgery for patients with stage IB1 cervical cancer with tumors 2 cm or larger: A literature review and analysis of oncological and obstetrical outcomes. Gynecol Oncol 137(3):574–580
Lu Q, Liu C, Zhang Z (2014) Total laparoscopic radical trachelectomy in the treatment of early-stage cervical cancer: review of technique and outcomes. Curr Opin Obstet Gynecol 26(4):302–307
Ghadjar P et al (2015) Modern radiation therapy and potential fertility preservation strategies in patients with cervical cancer undergoing chemoradiation. Radiat Oncol 10:50
Hwang JH et al (2012) Association between the location of transposed ovary and ovarian function in patients with uterine cervical cancer treated with (postoperative or primary) pelvic radiotherapy. Fertil Steril 97(6):1387–1393 (e1–e2)
Gottschalk E et al (2011) Pregnancy after lymphadenectomy and neoadjuvant chemotherapy followed by radical vaginal trachelectomy in FIGO stage IB1 cervical cancer. Fertil Steril 95(7):2431 (e5–e7)
Dargent D (2001) Radical trachelectomy: an operation that preserves the fertility of young women with invasive cervical cancer. Bull Acad Natl Med 185(7):1295–1304 (discussion 1305–1306)
Plante M et al (2011) The vaginal radical trachelectomy: an update of a series of 125 cases and 106 pregnancies. Gynecol Oncol 121(2):290–297
Hauerberg L et al (2015) Vaginal Radical Trachelectomy for early stage cervical cancer. Results of the Danish National Single Center Strategy. Gynecol Oncol 138(2):304–310
Ma LK et al (2014) Pregnancy outcome and obstetric management after vaginal radical trachelectomy. Eur Rev Med Pharmacol Sci 18(20):3019–3024
Diedrich K, Fauser BC, Devroey P (2011) Cancer and fertility: strategies to preserve fertility. Reprod Biomed Online 22(3):232–248
Meirow D et al (2015) Optimizing outcomes from ovarian tissue cryopreservation and transplantation; activation versus preservation. Hum Reprod 30(11):2453–2456
Diedrich K, Safaa A‑H (2015) Möglichkeiten und Grenzen der assistierten Reproduktion (ART) – eine nicht nur technologische Betrachtung. Forschung Medizin – Exzellenforschung in der Medizin: Frauenheilkunde. Neue Forschungen für die Frauengesundheit, S 6. Institut für wissenschaftliche Veröffentlichungen. ISSN 2191-9003 Ausgabe 6. S 19–23. Herausgeber ALPHA Informationsgesellschaft mbH, Lampertheim. Berlin-Brandenburgische Akademie der Wissenschaften
Balan R et al (2011) Immunohistochemical evaluation of COX-2 expression in HPV-positive cervical squamous intraepithelial lesions. Rom J Morphol Embryol 52(1):39–43
Hoellen F, Diedrich K, Beyer DA, Thill M (2012) Zervixkarzinom in der Schwangerschaft. Gynäkologe 45:939–944
Connolly TP, Evans AC (2005) Atypical Papanicolaou smear in pregnancy. Clin Med Res 3(1):13–18
Han SN et al (2013) Cervical cancer in pregnant women: treat, wait or interrupt? Assessment of current clinical guidelines, innovations and controversies. Ther Adv Med Oncol 5(4):211–219
WHO (2015) Cervical cancer: estimated cancer incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer, Lyon
Hoellen F et al (2012) Cancer in pregnancy. Part I: basic diagnostic and therapeutic principles and treatment of gynecological malignancies. Arch Gynecol Obstet 285(1):195–205
Amant F et al (2014) Gynecologic Cancers in Pregnancy Guidelines of a Second International Consensus Meeting. Int J Gynecol Cancer 24(3):394–403
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
F. Hoellen, C. Banz-Jansen und K. Diedrich geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Additional information
Redaktion
D. Beyer, Kaiserslautern
N. Maass, Kiel
K. Diedrich, Hamburg
Rights and permissions
About this article
Cite this article
Hoellen, F., Banz-Jansen, C. & Diedrich, K. Kinderwunsch und Schwangerschaft bei Zervixkarzinom und Vorstufen. Gynäkologe 49, 340–347 (2016). https://doi.org/10.1007/s00129-016-3839-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-016-3839-8